Page last updated: 2024-10-16

carbamates and Respiratory Distress Syndrome

carbamates has been researched along with Respiratory Distress Syndrome in 2 studies

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Pneumonia is a frequent complication of cholinesterase inhibitor poisoning (CIP) and a risk factor for death."1.36Early onset pneumonia in patients with cholinesterase inhibitor poisoning. ( Hsu, JY; Hung, DZ; Tsan, YT; Wang, CH; Wang, CY; Wu, CL, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, CY1
Wu, CL1
Tsan, YT1
Hsu, JY1
Hung, DZ1
Wang, CH1
Mitsuhashi, H1
Nonaka, T1
Hamamura, I1
Kishimoto, T1
Muratani, E1
Fujii, K1

Other Studies

2 other studies available for carbamates and Respiratory Distress Syndrome

ArticleYear
Early onset pneumonia in patients with cholinesterase inhibitor poisoning.
    Respirology (Carlton, Vic.), 2010, Volume: 15, Issue:6

    Topics: Aged; Carbamates; Cholinesterase Inhibitors; Female; Gastric Lavage; Humans; Insecticides; Male; Mid

2010
Pharmacological activities of TEI-8362, a novel inhibitor of human neutrophil elastase.
    British journal of pharmacology, 1999, Volume: 126, Issue:5

    Topics: Animals; Butyrates; Butyric Acid; Carbamates; Cricetinae; Enzyme Inhibitors; Humans; Leukocyte Elast

1999